Entero Healthcare Solutions has scheduled its 8th Annual General Meeting (AGM) for Wednesday, August 19, 2026. The meeting is set to commence at 12:30 PM IST and will be conducted via Video Conferencing (VC) or Other Audio-Visual Means (OAVM), allowing shareholders to participate remotely without physical presence. This arrangement ensures broader accessibility for investors while adhering to regulatory guidelines for corporate governance during ongoing operational constraints.

The company issued the formal intimation on July 23, 2026, publishing newspaper advertisements in "Financial Express" (English) and "Satyajay Times" (Hindi). Sanu Kapoor, Vice President - Group General Counsel, Company Secretary & Compliance Officer, signed the communication to the listing compliance departments of both BSE Limited and National Stock Exchange of India Limited. The filing confirms that all necessary procedural steps for the remote AGM have been completed.

Meeting Details

Shareholders are advised to refer to the official meeting notice for agenda items and voting instructions. The company has made the relevant information available on its website at www.enterohealthcare.com , ensuring transparency and easy access to corporate documents. Investors should monitor the site for any further updates regarding e-voting timelines or technical requirements for joining the virtual session.

Corporate Governance Update

The decision to hold the AGM remotely reflects the company's commitment to maintaining continuous engagement with its investor base. By utilizing VC/OAVM facilities, Entero Healthcare Solutions ensures that geographical barriers do not hinder shareholder participation. The compliance officer’s signature on the exchange filing validates the authenticity of the announcement and aligns with SEBI regulations concerning general meetings.

Investors holding shares in physical or demat form can access the annual report and other statutory filings linked to this AGM through the company’s investor relations portal. The seamless digital execution of the AGM underscores the firm's adoption of modern technological tools for corporate administration.

Entero Healthcare Solutions Limited has accepted the decision of Independent Director Rajesh Shashikant Dalal to not seek re-appointment for a second term. His current term concludes on August 24, 2026, marking the end of his tenure with the company. This transition impacts the composition of the board and its key committees effective the close of business hours on the specified date.

Rajesh Shashikant Dalal communicated his decision via email on July 13, 2026, stating he did not wish to be re-elected to the board upon the completion of his first term. Consequently, he will cease to be a Non-Executive Independent Director. The company has informed the stock exchanges regarding this change in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The departure involves the relinquishment of specific committee roles held by Dalal. He will step down as the Chairperson of the Nomination and Remuneration Committee and the Stakeholders Relationship Committee. Additionally, he will cease to be a member of the Audit Committee of the Board.

The following table summarizes the details of the cessation:

The disclosure was submitted to BSE Limited and the National Stock Exchange of India Limited by Sanu Kapoor, Vice President - Group General Counsel, Company Secretary & Compliance Officer. The information is also available on the company's official website.